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I.INTRODUCTION 
Pregnancy brings happiness to mothers but at times brings hypertension 
to mothers.Hypertensive disorders complicating pregnancies forms one of the 
deadly triads along with hemorrhage and infections that results in much of the 
maternal morbidity and mortality in pregnancy.Hypertensive disorders 
complicate 5-10% of all pregnancies. WHO systematically reviews maternal 
mortality worldwide and found that 16% of maternal deaths are due to 
hypertensive disorders.The mystery how pregnancy incites or aggravates 
hypertension is still unresolved. 
Pre-eclampsia is diagnosed when hypertension and proteinuria occur after 
20 weeks of gestation. Edema is often seen but is not required to make the 
diagnosis. Proteinuria is an important sign of preeclampsia. It reflects the 
glomerular damage that causes leakage of proteins through the basement 
membrane. 
There are so many components which determine the severity of hypertension. 
Of which proteinuria is important to classify the type of hypertension. Presence 
of proteinuria differentiates gestational hypertension and preeclampsia.It is 
directly proportional to maternal and perinatal morbidity and mortality. Severity 
of preeclampsia is also determined by the degree of proteinuria hence accurate 
and rapid quantification of proteinuria is essential for the diagnosis and 
management of hypertensive disorders. 
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Routinely proteinuria in pregnancy is detected by urine dipstick  
Method which is not accurate and there are false positives and false negatives. 
The gold standard 24hrs urine protein though accurate is time consuming and 
requires patient compliance which can be rectified by shorter collection 
specimens  (12hrs) which gives similar results as 24 hrs urine protein. 
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II. REVIEW OF LITERATURE 
Pregnancy can cause hypertension in previously normotensive women and can 
aggravate already existing hypertension. Preeclampsia is a pregnancy specific 
disorder which leads toplacental dysfunction and maternal complications. 
Preeclampsia canmanifest either as a maternal syndrome or as a fetal syndrome. 
Thehallmark of preeclampsia is hypertension along with proteinuria(1). Edema is 
not an essential criteria for the diagnosis of preeclampsia. 
Hypertension in pregnancy can be defined as  
 Systolic Blood Pressure   140 mm Hg 
 Diastolic Blood Pressure  90 mm Hg 
Recorded on two occasions six hours apart within seven days (2).Blood Pressure 
should be recorded in sitting posture with right arm well supported in horizontal 
position at the level of heart.  
GOLD STANDARD for the measurement of blood pressure is by mercury 
sphygmomanometer. An adequate size cuff isUsed. Korotkoff V is used as an 
index of Diastolic blood pressure. 
  
 “PROTEINURIA in hypertensive disorders of pregnancy is definedas          
>300mg of protein excretion in a 24 Hrs urine sample. Spot Protein Creatinine 
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Ratio > 0.3 mg. Dipstick reading > 1+ in two random urine samples collectedsix 
hours apart.” (3) 
HISTORICAL ASPECTS OF PREECLAMPSIA: 

 
Defined as toxaemia by ZWEIFF. 

 
Defined as Disease of Theories by CHESLEY AND ZWEIFF. 

 
Relation of Essential Hypertension to preeclampsia described by 
FISHBERG. 

 
Discovery of proteinuria in preeclampsia by LEVER AND SIMPSON. 

 
Physiological and functional changes in glomeruli described by 
LABLEIN AND FAHR. 

 
Electron Microscopic demonstration of Glomerular Capillary 
Endotheliosis by FARGUHER
.
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CLASSIFICATION: 
There are various classifications for hypertensive disorders of pregnancy. Due 
to lack of knowledge of the precise nature of thedisorder and difference of 
opinion in the clinical and pathologicalfeatures an agreed classification is yet to 
put forward. 
The Worldwide accepted classification is theNATIONAL HIGH BLOOD 
PRESSURE EDUCATION PROGRAMMEoftheworking group (2000) ( 4 ). 
According to that Hypertensive disorders areclassified as 
 Gestational Hypertension 
 Preeclampsia 
 Eclampsia 
 Preeclampsia superimposed on chronic Hypertension 
 Chronic Hypertension. 
GESTATIONAL HYPERTENSION: 
Also called as Transient Hypertension of pregnancy. “Blood Pressure 140/90 
mm Hg recorded for the first time during pregnancy after 20 weeks of 
gestation.No associated proteinuria. Blood pressure becomes normal within 12 
weeks postpartum (5).Retrospective diagnosis made postpartum.” 
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PREECLAMPSIA:     
 The hallmark of preeclampsia is Hypertension associated with proteinuria 
developing after 20 weeks in a previously normotensive woman. 
MINIMUM CRITERIA:   “Blood pressure  140/90 mmHg recorded for the 
first time after 20 weeks of gestation.Proteinuria of  300mg in 24 Hrs or > 1+ 
dipstick.” 
ACOG Classifies preeclampsia as ( 6 ) 
Features mild/non severe Severe 
diastolic blood pressure < 110mmhg 110 mmhg 
systolic blood pressure < 160mmhg 160mmhg 
Proteinuria 2+  3+ 
headache/ visual disturbances Absent Present 
epigastric pain/oliguria Absent Present 
serum Creatinine Normal >1.2mg/dl 
Thrombocytopenia Absent <1,00,000 
pulmonary edema absent  Present 
iugr/ oligohydramnios Absent Present 
ast/ alt minimally elevated marked elevation 
Ldh Absent ldh >600 
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ECLAMPSIA: 
Occurrence of tonic clonic seizures in a women with Preeclampsia which is not 
attributable to any other cause. 
PREECLAMPSIA SUPERIMPOSED ON CHRONIC 
HYPERTENSION(7): 
“New Onsetof Proteinuria>300mg/ 24 hrs in ahypertensivewomen with no 
proteinuria before 20weeks, 
          Sudden increase in proteinuria or blood pressure or fall in platelet count< 
one lakh in a hypertensive women with proteinuria before 20 weeks.” 
CHRONIC HYPERTENSION: 
“Blood Pressure > 140/90mmHg before pregnancy or diagnosed before 
20weeks of gestation. 
Hypertension first diagnosed after 20 weeks but persists after 12 weeks 
postpartum.” 
INCIDENCE: 
 Gestational Hypertension – 5%  
 Preeclampsia –Williams :5-7% 
 Mudaliar and Menon : 8-10% ( 8 ) 
 De Sweit : 3-7% 
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 Primi gravida- 7% 
 Multigravida -5% 
 Superimposed preeclampsia -25% 
 Chronic Hypertension -1-2%  
 Eclampsia -0.5-2% 
RISK FACTORS FOR PREECLAMPSIA                 
PRIMIGRAVIDA: 
According to McGillivray preeclampsia occurs in primi gravida 15 times more 
commoner than parous women. 
PRIMIPATERNITY: 
There is a inverse relationship between the partner and occurrence of 
preeclampsia. Hence not only the first pregnancy is a risk factor but also the 
first pregnancy by the existing partner. (9 – 14)Recent epidemiologic studies 
suggest that multiparous women withdifferent partners have a higher risk for 
pre-eclampsia than domultiparous women with the same partner, perhaps 
because of a protective effect of repeated exposure to specific antigens. 
INCREASING MATERNAL AGE: 
Robillard and Haley et al states that an extreme of age is a risk factor for the 
development of preeclampsia. 
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FAMILY HISTORY: 
There is a genetic relationship in the development of preeclampsia. Daughters 
of mothers who had preeclampsia has a 25% risk of developing preeclampsia. 
RECURRENT PREECLAMPSIA: 
Recurrence risk is between 2 -25% ( 15 ) 
OBESITY:  
SIBAI et al showed that obesity perse is a independent riskfactor for the 
development of Hypertension. It also forms a component of metabolic 
syndrome which increases the risk of preeclampsia. 
MEDICAL DISORDERS: 
 Diabetes increases the risk by 30%.  
 Chronic Hypertension increases the risk by 3-7%, ( 18 ) 
 Antiphospholipid antibody syndrome and thrombophilias had a strong 
correlation with preeclampsia.( 19 – 21 ) 
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RISK FACTORS FOR PREECLAMPSIA 
COUPLE RELATED RISK FACTORS: 
 Prim paternity and limited sperm exposure 
 Pregnancy after artificial insemination 
 Protective effect of partner change in case of previous 
preeclamptic pregnancy 
 
MATERNAL OR PREGNANCY RELATED RISK FACTORS: 
 Extremes of maternal age 
 Multifetal gestation, preeclampsia in previous pregnancy 
 Chronic hypertension or renal disease 
 Antiphospholipid antibody syndrome, thrombophilias 
 Obesity and diabetes  
 Family history of preeclampsia 
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THEORIES REGARDING CAUSATION OFPREECLAMPSIA: 
According to various theories regarding the pathophysiology of preeclampsia a 
women is likely to develop hypertensive disorders during pregnancy when 

 She is exposed for the first time to chorionic villi, ( 25 ) 

 She is exposed to abundance of chorionic villi like molar pregnancy 
and multiple pregnancies. 

 When she already has vascular disease, 

 There is genetic predisposition. 
TWO STAGE HYPOTHESIS: 
According to this hypothesis there occurs poor placentation due to faulty 
endovascular trophoblastic remodelling which occurs during first half of 
pregnancy (stage 1) which leads to poor placentation leading to ( stage 2) 
clinical syndrome which is characterised by activation of maternal systemic 
inflammatory stress and clinical signs of preeclampsia. 
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THE TWO STAGE MODEL OF PRE-ECLAMPSIA: 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
        Stage 1 
First half of Pregnancy 
Poor 
placentation                
No symptoms 
Placental oxidative stress 
and inflammation 
Stage 2 
Second half of 
Pregnancy 
Overt 
Preeclampsia 
sFlt – 1 and 
syncytiotrophoblast 
factors 
Maternal systemic 
inflammatory stress 
Clinical signs of 
Preeclampsia 
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ABNORMAL TROPHOBLASTIC INVASION: 
 During pregnancy there occurs a physiological change in the spiral arterioles 
which convert them into uteroplacental arteries which occurs in two stages. 
During the first stage there occurs endovascular trophoblastic invasion of the 
decidual segment of the spiral arterioles. During 16 to 20 weeks of gestation 
there occurs secondary trophoblastic invasion of the myometrial segment of 
spiral arterioles which converts them into more elastic tortuous easily 
distensible channels(26 -27). 
 
FIGURE:1: Trophoblastic Invasion 
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In preeclampsia these vascular changes does not occur and the myometrial 
segments of the spiral arterioles are left with muscular lining which leads to 
decreased distensability and becomes hyper responsive to the hormonal 
changes.( 28 -29 ) 
IMMUNOLOGICAL THEORY: 
There is a disturbance in the immunological balance between the maternal and 
fetal system in preeclampsia which interferes with the remodelling of spiral 
arterioles by the trophoblastic cells which leads to fetoplacental hypoperfusion.( 
30 ) 
In preeclampsia there occurs imbalance between the formation of maternal 
antibodies and the fetal antigenic load and the formation of blocking antibodies 
is impaired (BARDEQUE  and associates 1999).In preeclampsia the immune 
system is hyper responsive since the normal immunosupression which prevents 
the fetal allograft rejection is impaired (LABARRERE 1998 )( 31 ). 
T Lymphocytes levels are lower in preeclampsia (32 ) which leads to decreased 
levels of cytokines which leads to poor implantation and dysfunction (HYASHI 
and associates 2000 ).(33 -34 ) 
HLA-G which is a immunosuppressant is expressed by cytotrophoblast and protect the 
trophoblast from destruction by the NK Cells.In a women with preeclampsia the 
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level of HLA-G is low and recognition of Fetal cytotrophoblast as foreign 
antigens(35 -36). 
GENETIC PREDISPOSITION: 
NISSAN et al showed that there is a strong genetic predisposition of 
31% in Preeclampsia(37). 
 Hypertensive disorders of pregnancy are inherited both by single 
gene and multifactorial inheritance (BROUGHTON PIPLUS 
1999)(40). 
 Single recessive model with a frequency of 0.25% with Genes 
acting on mother on ch 1, 3, 9.  
Dominant model with incomplete penetrance. 
 Mother to daughter transmission is through HLA DR4.( 
KILPATRIK et al ) (41).  
 Higher incidence in women carrying Angiotensinogen gene variant 
T235 ( ARNGRIMSSON et al )( 42 ) . 
 Association between proteinuric hypertension and HLADR4 has 
been reported. 
 Incidence of factor V Leiden mutation polymorphism variant 
20210A.  
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 Epigenetic features or imprinting locus on ch 10q22 is also 
involved (DUDEJANS et al ).Increased level of MTHFR gene mutation 
homozygosity (COFFER et al) ( 44 ) 
ENDOTHELIAL DYSFUNCTION: 
The endothelium plays a major role in the pathophysiology of preeclampsia 
indicated by the imbalance between prostacyclin and thromboxane ( 40 – 42 ) and 
decreased synthesis of nitric acid. In preeclampsia endothelial cell dysfunction 
and platelet aggregation precedes increase in thrombi and fibrin formation (43 – 46 
)
. 
According to MAYNARD et al ( 47 ) in preeclampsia there is increased 
production of soluble fms like Tyrosine kinase 1( sflt-1) by the placenta .It 
binds to the receptor binding domain of Vascular Endothelial Growth Factor( 
VEGF) and Placental Like Growth Factor (PLGF) leading to decreased levels of 
VEGF and PLGF resulting in endothelial dysfunction (48 -50 ). 
According to LEVINE et al (57 -58 ) there is increased levels of soluble Endoglins 
S (Eng ) in preeclampsia which decreases Nitric oxide production leading to 
vasoconstriction and preeclampsia. 
Deficient trophoblastic invasion which is immunologically mediated leads to 
release of placental factors into maternal circulation and causes damage to the 
vascular endothelium (60 ). 
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WANG et al ( 61 )studied the imbalance between TXA2 and PGI2 with increased 
levels of TXA2 leading to vasoaggregation and endothelial damage. 
Endothelin -1 a potent vasoconstrictor level is increased in preeclampsia 
(CLARK SCHIFF) (62). 
 
 
 
19 
 
 
 
 
 
20 
 
ENDOTHELIAL FACTOR: 
Endothelial cell activation is the central event in the pathophysiology 
 of preeclampsia. The normal endothelium is lined by a single layer  Of 
squamous epithelial cells which lines the vascular lumen which functions as 
follows 
 It plays an important role in haemostasis and decreases vascular smooth 
muscle response to vasopressors. 
 It has anticoagulant properties and prevents clot formation. 
 When the endothelium is damaged there occurs increased coagulation due 
to increased sensitivity to pressor agents. 
NITRIC OXIDE: 
Endothelium in normal pregnancy produces Nitric Oxide which is a derivative 
of L-Arginine is a potent vasodilator which maintains a low pressure low 
resistance state in the fetoplacental unit (63 ). 
There are various studies which shows decreased Nitric Oxide levels in 
preeclampsia. WANGand colleagues’ 2004 showed an increased level of Nitric 
Oxide in severe preeclampsia which is a compensatory process which signifies 
worsening of disease. 
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Nitric Oxide acts along with prostacyclin which is a potent vasodilator and 
platelet aggregator. In preeclampsia there is an imbalance between prostacyclin 
and thromboxane and decreased synthesis of nitric acid leading to 
vasoconstriction (65-66 ). 
OXIDATIVE STRESS: 
At present themost accepted theory is “OXIDATIVE STRESS “.  Reduced 
placental perfusion leads to increased levels of prooxidants over antioxidants 
and release of free radicals. This imbalance between antioxidants and 
prooxidants results in oxidative stress which leads to increased TXA2 levels and 
decreased PGI2 levels and causes endothelial dysfunction ( 67 ). 
In preeclampsia there is decreased expression of thioredoxin and glutaredoxin in 
the placenta which leads to greater accumulation of modified renal proteins 
which are the markers for lipid per oxidation in the placenta of preeclampsia. 
There occurs increased production of nitric oxide in preeclampsia as a 
compensatory process which competes with superoxide dismutase and 
combines with superoxide. 
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VASOSPASM: 
VOLHARD et al states that the hallmark of preeclampsia is vasospasm. 
Vasospasm leads to endothelial damage and interendothelial cell leakage leads 
to deposition of fibrin and platelets in the sub endothelium and causes 
uteroplacentalinsufficiency. 
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INCREASED PRESSOR RESPONSE: 
Normally during pregnancy there occurs refractoriness to the pressor effects of 
Angiotensin II. For the maintenance of normal vascular refractoriness an 
adequate balance between the production and metabolism of vasoactive 
prostaglandins is responsible. In preeclampsia when compared to normal 
pregnancy this ratio is altered and there is decrease in the production of PGE2 & 
PGI2 and increased production of TXA2 which leads to increased sensitivity of 
vasoactive amines causing vasoconstriction. 
ABNORMAL TROPHOBLASTIC INVASION: 
During pregnancy there occurs a physiological change in the spiral arterioles 
which convert them into uteroplacental arteries which occurs in two stages. 
During the first stage there occurs endovascular trophoblastic invasion of the 
decidual segment of the spiral arterioles. During 16 to 20 weeks of gestation 
there occurs secondary trophoblastic invasion of the myometrial segment of 
spiral arterioles which converts them into more elastic tortuous easily 
distensible channels. 
           In preeclampsia these vascular changes doesnot occur and the 
myometrial segments of the spiral arterioles are left with muscular lining which 
leads to decreased distensibility and becomes hyperresponsive to the hormonal 
changes. 
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FIGURE:2: Demonstrates The Pathophysiology Of  
Preeclampsia And Its Consequences. 
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PATHOPHYSIOLOGICAL CHANGES: 
HAEMODYNAMIC CHANGES: 
 In preeclampsia there occurs generalised vasospasm in contrast to normal 
pregnancy which shows hypervolemia and hence there is decrease in 
preload. 
 Due to increase in vascular resistance there is increase in 
afterload.Increased afterload causes decreased cardiac output. 
 Due to increase in cardiac output and vascular resistance MAP increases. 
 Haemoconcentration is the hallmark of preeclampsia. 
 Reduced circulating blood volume in women homozygous for T235 
angiotensin gene type associated with preeclampsia. (Silver and 
Associates 2001 ). 
 Increased sensitivity to Angiotensin II. 
 Increased peripheral resistance. 
 Increased blood pressure. 
 Intrinsic renal changes. 
 Reduced renal blood flow. 
 Reduced glomerular function. 
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HAEMATOLOGICAL CHANGES: 
THROMBOCYTOPENIA: 
It occurs in 10 -20 % of cases of preeclampsia. It occurs as an immunologically 
mediated process due to increased platelet deposition at the site of endothelial 
damage. The severity of thrombocytopenia is directly proportional to the 
maternal and fetal morbidity and mortality. 
COAGULATION SYSTEM: 
The presence of fibrin and thrombin in the microvasculature of various organs 
suggests that preeclampsia is a hypercoagulable state. The vasospasm which is 
characteristic of preeclampsia causes endothelial injury which favour fibrin 
deposition in microvasculature. 
INCREASED DECREASED 
Activity of intrinsic pathway 
factors↑FV IIIa: FV IIIc activity      
Thrombin : Antithrombin ratio 
 ↑Platelet aggregation                            
 
Antithrombin III 
 Fibrinogen 
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CARDIOVASCULAR CHANGES: 
 Sensitivity to Angiotensin II is increased.  
 Haemoconcentration and decreased circulatory blood volume. 
 Increase in heart rate and hyper dynamic ventricular function. 
 Increase in peripheral resistance. 
RENAL SYSTEM: 
 Reduced renal blood flow and glomerular function.  
 Intrinsic renal changes.  
 Reduced uric acid clearance 
 Proteinuria Glomerular capillary endotheliosis.  
ACUTE RENAL FAILURE: 
Acute tubular necrosis is rarely associated with isolated preeclampsia. When 
preeclampsia is associated with either abruption or HELLP there is more 
probability of acute tubular necrosis. Irreversible cortical necrosis develops 
rarely. 
HEPATIC SYSTEM: 
Involvement of hepatic system was first described by VIRCHOW in 1856.In the 
periphery of the liver there are regions of periportal haemorrhage. Liver 
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involvement associated with haemolysis, thrombocytopenia and elevated liver 
enzymes is popularly termed as HELLP. 
Clinically manifests as epigastric pain or tenderness in the upper epigastrium 
and are associated with elevated AST & ALT. 
Sometimes presents as asymptomatic elevations of AST & ALT and platelet 
count which normalises following delivery within three days. 
Infarction in the liver can lead to hepatic haemorrhage which inturn leads to 
hepatic haematoma causing subcapsular haemorrhage. MRI & CT are used in 
the diagnosis .Most of them are treated conservatively however surgical 
intervention is life saving in few cases. 
Women with HELLP syndrome have increased risk of associated complications 
like Eclampsia, Abruptio placenta, pulmonary edema, coagulopathy, Acute 
renal failure, compared to women with isolated preeclampsia. 
BRAIN: 
Visual symptoms and headache are commly associated with severe 
preeclampsia. When it is associated with convulsions it is termed as eclampsia. 
Cerebral involvement can be identified by  MRI,CT,Doppler studies. 
 
PATHOPHYSIOLOGY:  
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There are two theories which explains the pathophysiological changes, 
 In response to acute or severe hypertension 
Cerebral overregulation 
Vasospasm 
Ischemia 
Cytotoxic edema 
Infarction 
sudden increase in blood pressure 
Exceeds normal cerebral auto regulation at capillary level 
Increased hydrostatic pressure, hyper perfusionextravasations of plasma ,  
Vasogenic edema  
CLINICAL FEATURES: 
 Headache and Scotomas: Occurs due to cerebral hyper perfusion 
more in the occipital lobe. 
 Convulsions: Are diagnostic of eclamps.  
 BLINDNESS occurs when preeclampsia is associated with 
eclampsia. 
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 Cerebral edema leads to altered mental status , confusion and coma. 
Sometimes can lead to fatal supratentorial herniation. 
VISUAL CHANGES:  
Blurringof vision,scotoma, Diplopia are associated with severe preeclampsia. 
Blindness when occurs is usually reversible occurs due to involvement of retina, 
occipital lobe,and lateral geniculate body. 
Purtscher retinopathy is the term used to describe the blindness that occurs due 
to retinal ischemia or infarction. Altered vision can also occur due to retinal 
detachment which is mostly unilateral. 
UTEROPLACENTAL INSUFFICIENCY:  
Vasospasm leading to compromised uteroplacental perfusion contributes to the 
perinatal morbidity and mortality. Uterine artery blood flow measurement 
estimates uteroplacental perfusion. With abnormal placentation high resistance 
persists in the uterine artery. Persistant uterine artery notching is associated with 
increased risk of IUGR or preeclampsia. 
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PREDICTORS OF PREECLAMPSIA: 
There are tests which can predict the occurance of preeclampsia. The various 
tests are 
 Tests depending on blood pressure measurement.  
 Urine assay.  
 Blood assay.  
 Angiotensin I sensitivity test. 
TESTS DEPENDING ON BLOOD PRESSURE MEASUREMENT: 
ROLL OVER TEST: 
The patient is asked to lie in lateral decumbent position and blood pressure is 
measured, then after 5 minutes patient is asked to lie supine and blood pressure 
is recorded again. An increase in blood pressure reading >    mmHg  
MID TRIMESTER MEAN BLOOD PRESSURE: 
Mean arterial blood pressure >90 mmHg has more than four fold increase in 
risk of preeclampsia. 
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HAND GRIP TEST: 
Isometric sustained contraction of striated muscle generates sympathetic activity 
increases arterial blood pressure. The patient compresses an inflated 
sphygmomanometer cuff at its maximumfor 3 minutes and then at 50% of 
maximum. An increase in DBP >20mmHg at 28-30 wks increases the risk. 
URINE ASSAY 
 Microalbuminuria:Detected by radioimmunoassay before albuminuria 
can be detected by ordinary methods.  
 24 Hrs Urine Calcium:  excretion is decreased in women with 
preeclampsia than normal women. 
 Kallikerin Vs Creatinine: Ratio decreases in patients who are prone for 
preeclampsia. 
BLOOD ASSAYS: 
 PLASMA URATE LEVELS serial increase is a warning of PIH before 
appearance of other clinical features.  
 Reduced platelet count occurs early in preeclampsia.  
 Antithrombin III activity begins to decline as much as 13 wks prior to 
the development of manifestations of preeclampsia. 
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ANGIOTENSIN II SENSITIVITY TESTS: 
 Sensitivity to infused angiotensin II is increased due to alteration in 
the vascular smooth muscle AT II receptors.  
 Platelet and angiotensin binding is increased before development of 
preeclampsia. 
COMPLICATIONS OF HYPERTENSIVE DISORDERS OF 
PREGNANCY: 
MATERNAL: 
 Eclampsia.  
 Abruptio placenta.  
 HELLP Syndrome.  
 Rupture of liver.  
 Pulmonary Edema.  
 Cerebral Haemorrhage.  
 Retinal Detachment. 
FETAL COMPLICATIONS: 
 Prematurity.   
 IUGR.  
 Oligohydramnios. 
35 
 
  ICH.  
 Respiratory Distress.  
 Magso4 to mother causes neonatal depression. 
PROTEINURIA 
Proteinuria is defined as urinary protein excretion of>150 mg/ day in a 24 hr 
urine collection. It denotes an increased glomerular permeability of the plasma 
macroglobulin albumin which is normally not filtered in the urine. 
Normally urine protein excretion per day is < 150 mg of which albumin 
constitutes 60% and tubular Tam Horsfall protein 40%. 
Proteinuria in pregnancy is defined as an urinary protein excretion of > 300mg/ 
day in a 24 hr urine collection. Incidence of proteinuria in pregnancy is 5% (68). 
Though proteinuria indicates the severity of the disease absence of it does not 
exclude the severity of preeclampsia. There are cases where preeclampsia and 
eclampsia occur without proteinuria (69). 
TYPES OF PROTEINURIA 
GLOMERULAR PROTEINURIA: 
It is characterised by proteinuria due to damage to the basement membrane. It 
occurs in glomerular disease and is also termed as albuminuria.The glomerulus 
which behaves as an ultra filterfor plasma proteins is composed of endothelial 
cells, basement membrane and epithelial foot processes. The filtration process 
depends upon 
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MOLECULAR SIZE: 
There is an inverse relationship between the size of the particle and glomerular 
filtration. IgM which is a HMW protein cannot undergo filtration whereas 
albumin a LMW protein can easily pass through the filter. 
CHARGE: 
Endothelial cells and the basement membrane normally posses a negative 
charge which repels the negatively charged proteins like plasma albumin. 
CONCENTRATION IN PLASMA: 
Higher the plasma concentration the more it appears in the urine, hence albumin 
appears in the urine when compared to low concentration proteins. 
RESORPTION BY RENAL TUBULES: 
Albumin is less absorbed when compared to VLMW Proteins and hence about 
60% appears in urine. In selective proteinuria LMW proteins are filtered 
whereas in non selective proteinuria the filtration is independent of the 
molecular weight. 
FUNCTIONAL PROTEINURIA: 
It is related to alterations in blood flow throughout the glomeruli. Whenever 
there is excessive blood flow like fever, exercise and increased stress there 
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occurs functional proteinuria with protein excretion <1 gm/day.The condition 
becomes normal once the precipitating event is withdrawn. 
POSTURAL /ORTHOSTATIC HYPERTENSION: 
Increase in proteinuria with upright position is called postural proteinuria with 
excretion >1 gm/day. Whenpersistent signifies renal pathology. 
TUBULAR PROTEINURIA: 
It occurs due to tubular or interstitial injury which impairs the reabsorption of 
Low Molecular Weight protein and hence they appear in urine(70). 
OVERLOAD PROTEINURIA: 
It occurs when the reabsorptive capacity is impaired as a result of increased 
production of protein and the excess protein is filtered in the urine. 
MICROALBUMINURIA: 
Excretion of >30mg and <300mg/ day of albumin. It is the earliest evidence of 
type 1 diabetes. 
KIDNEYS IN NON PREGNANT WOMEN: 
The upper limit of protein excretion is 150 mg /dl of which 40% forms albumin 
and 60% Tomm Horsfall protein. 
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There are various factors like size, charge, molecular weight which influences 
the movement of protein across the glomerular capillary bed. The proximal 
tubular epithelial cells absorbs the protein filtered by the glomeruli by 
endocytosis,but this process is saturated with high glomerular protein load and 
causes proteinuria. 
KIDNEY IN UNCOMPLICATED PREGNANCY: 
There are both anatomical and physiological alterations in kidney during 
pregnancy. The kidneys increase in size and there is enlargement of renal calyx, 
renal pelvises and ureters enlarge more commonly on the right side under both 
hormonal influence and obstruction. There is increase in renal plasma flow and 
glomerular filtration rate. There is increase in creatine clearance which causes 
decreased serum Creatinine levels. 
PROTEINURIA AND PREECLAMPSIA:  
Proteinuria forms an essential criteria for the diagnosis of preeclampsia. The 
presence of proteinuria can lead to many pregnancy complications from urinary 
tract infections to chronic renal disease. It is the hallmark of preeclampsia and 
the degree of proteinuria is a sign of worsening of hypertensive disorders. 
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KIDNEY CHANGES IN PREECLAMPSIA: 
Both morphological and functional characteristics of kidney are affected in 
preeclampsia. Since the glomerulus is affected there is excretion of albumin in 
the urine. Preeclamptic glomeruli undergo structural changes with hypertrophy 
of cytoplasmic organelles and endothelial vacuolisation as defined as 
glomerular Endotheliosis. 
In preeclampsia due to hypertrophy and proliferation of intercapillary cells the 
glomeruli is bloodless and diffusely enlarged. Ultra structurally it is described 
as hypertrophy of cytoplasmic organelle in endothelium leading to marked 
enlargement and vacuolisation as a result of accumulation of free lipids. This is 
classically described as glomerulo capillary Endotheliosis . 
Preeclampsia can rarely cause acute renal failure which is due to tubular 
necrosis. When a major portion of cortex is damaged renal cortical necrosis 
occurs which is irreversible. 
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A: Normal glomeruli, B: Preeclamptic glomeruli, C: Electron microscopic 
picture of preeclamptic Glomeruli 
FIGURE: 3: Glomerulocapillary Endotheliosis 
PATHOPHYSIOLOGY OF PROTEINURIA IN PREECLAMPSIA: 
                          Spasm of glomerular arteries 
 Anoxia of glomeruli 
 Endothelial Damage 
                            Escape of proteins into urine 
PROTEINURIA AND CLINICAL OUTCOME: 
Significant proteinuria >300 mg/dl or > 2+ dipstick is associated with increase 
in perinatal morbidity like  fetal  growth restriction, stiilbirth, preterm deliveries 
before 37 wks and increased neonatal death. Even the trace proteinuria is 
associated with poor outcomes. 
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Ginsberg et al showed that the degree of proteinuria in both diagnostic and 
prognostic significance. 
Outcome of 400 pregnancies complicated by proteinuria and  hypertension are 
studied and found a four times of risk of perinatal morbidity and mortality in 
women with proteinuria than in non proteinuric group 
FERRAZZANI et al studied 444 hypertensive women with proteinuria and  
noted increase in levels of serum uric acid ,low birth weight and more deliveries 
before 37 completed weeks. 
Sudan et al showed that complications increases with the degree of proteinuria. 
In a prospective study by SCHIFF et al showed that in patients with proteinuria  
there is increased perinatal morbidity in terms of IUGR, LBW, NICU 
admissions. 
DIAGNOSIS: 
In all hospitals whether it is a primary health centre or a private hospital all 
antenatal women at their booking visit should be screened for proteinuria and 
also at subsequent visits. If the dipstick shows proteinuria it has to be evaluated 
(72)
. 
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DIPSTICK TEST: 
A Dipstick contains reagent for one or more tests for example ketone bodies , 
proteins and glucose(73). In the presence of proteins there is a colour change in 
the reactive portion of stick. The dipstick is buffered with citrate PH3 buffer and 
tetrabromophenol .In the presence of protein blue turns yellow. Since the first 
morning sample is more concentrated and less affected by postural factors it is 
usually preffered for detection of proteinuria. 
Due to alkaline and concentrated urine and also due to contamination by vaginal 
discharge there are large number of false positives (74) . Dilute urine may 
sometimes produce false negative reaction. 
Sudan et al showed that the high number of false negatives with urine Dipstick 
when compared to 24 hr urine measurement. 
Meyer et al found that Dipstick is a poor predictor of absent or severe 
proteinuria. 
Jasone et al showed Dipstick values of trace or 1+ correlates poorly whereas at 
higher degrees it correlates better. 
 TRACE      15mg/dl 
             1+             30mg/dl<0.5 gm/ day 
             2+            1oomg/dl                 0.5 -1 gm/ day 
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             3+             3oomg/dl                 1 -2 gm/ day 
             4+            2gm/dl                > 2gm /day 
 
FIGURE 4 : Urine Dipstick And Interpretation 
SULFOSALICYLIC ACID TEST: 
Detects protein by acid precipitation and any time of protein can be 
detected.Three parts of 3% sulfosalicylic acid is mixed with one part of urine 
and the amount of protein is quantified by an auto analyser. 
HEAT COAGULATION TEST: 
It is done by adding acetic acid 3 – 4 drops to urine after heating.  
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Depending upon the turbidity the results are graded. False positives and false 
negative results can occur. 
QUANTIFICATION OF PROTEIN: 
Quantification is important to differentiate proteinuria caused by various renal 
diseases. Tubulo interstitial diseases cause proteinuria of < 1 – 2 gm / day and 
glomerular disease > 3.5 gm/ day. Quantification is usually done by timed 
collections of which 24 HRS urine sample remains the gold standard. 
24 HOURS COLLECTION: 
It is the GOLD STANDARD for quantification of proteinuria. Protein excretion 
is variable in the setting of preeclampsia therefore it is recommended that 24 hr 
urine collection is used for the diagnosis .The combination of hypertension and 
diabetes during pregnancy markedly increases perinatal morbidity and 
mortality. Proteinuria is a sign of worsening of hypertensive disease and 
predicts the outcome of preeclampsia. Based on the degree of Proteinuria the 
management decision varies .Overestimation of Proteinuria leads to 
interventions that may end in preterm delivery whereas underestimation leads to 
delay in the diagnosis of severe nephropathy leading to kidney damage. 
Throughout the day there is variation in the rate of protein excretion which is 
secondary to vascular spasm and vasoconstriction producing fluctuation in 
protein excretion. There is an increase in Proteinuria in an upright positionand 
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ambulation causing vasoconstriction and increases glomerular permeability. 
These changes produces a diurnal  variation  in protein excretion. There occurs 
a circadian rhythm in the excretion of potein so there is a necessity for a 24hr 
urine collection for quantification of Proteinuria. In hospitalised patients there is 
not of much variation in the circadian rhythm and it is therefore possible to use 
shorter collection specimen. 
Although accurate 24 hr collection is time consuming and cumbersome and 
requires patient compliance hence it can be replaced by a shorter collection 
which gives a similar result. Kieler H, Zettergran T, Svensson H Showed that 
the goldstandad 24 hrs urine excretion for assessment of Proteinuria in 
preeclamptic women can be substituted by 12 hr urine collection .Study 
conducted by Haemak medical centre Israel comparing 24 hrs urine protein vs 
shorter period on 300 patients and found significant  correlation between the 
two.Mayo Clinic conducted a study which showed excellent correlation  
between 12 hrs and 24 hrs. 
Sherry Boschart et al during the management of preeclampsia instead of 24 hrs 
urine collection practiced 12 hrs urine  collection Spot urine samples are 
inaccurate and therefore not recommended for quantification  of Proteinuria . 
Minoo Rajaei et al studied 63 pregnant women and compared 24 hrs urine 
protein with 12 hrs urine protein and found that significant correlation with 
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sensitivity of 83% and specificity of 91%, positive predictive value of 80% & 
negative predictive value of 82%, pearson’s correlate was 0.890. 
Some investigators explored methods for quantifying proteinuria in a shorter 
period. The PCR of a single voided urine sample correlated with 24 hrs when 
proteinuria is < 1gm/day and poor correlation when proteinuria is > 2gm /day. 
Christina Tun MD et al studied 102 patients and compared spot PCR, 12 hrs 
urine protein and 24 hrs urine protein. Both 12 hrs and 24 hrs urine protein 
correlated well with 24 hrs urine protein.Jonne N Quinones et al studied 90 
women comparing spot PCR, 12 hrs and 24 hrs urine protein correlated better 
than PCR with sensitivity 96%& 89%, specificity 100%& 40% , positive 
predictive value 100% & 32% and negative predictive value 98% & 91% 
respectively 
Methods comparing 2 hrs, 8 hrs specimens are also studied. 2 hr specimen 
correlated with no proteinuria but does not correlate in cases of severe 
proteinuria. The need for 24 hrs collection is because of high degree of variation 
in the urine protein excretion throughout the day and the factors influencing are  
 Variation in water intake and excretion.  
 Rate of dieresis.  
 Diet.  
 Posture.  
 Exercise. 
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So a single sample spot PCR cannot accurately predict proteinuria and hence the 
need for shorter collection specimen which will give accurate result like 24 hrs 
specimen is appropriate. Our study is to find whether 12 hr collection correlates 
with 24 hrs collection. 
Sogra Rabiae et al studied 57 patients and showed 12 hr sample correlated with 
24 hrs sample for patients with no disease  (p < 0.02 ) mild proteinuria (p<0.02), 
sevsre proteinuria ( p < 0.01 ). 
.Irruae specialist teaching hospital issue compared 2 hr, 12 hr, & 24 hr urine 
specimen and found a P < 0.02 and sensitivity of 96%, specificity of 98% and 
Negative predictive value of 96%. 
F Tare, A Monsouri, F Ravanbaksh showed that shorter urine collection showed 
better correlation equal to 24 hr collection. 
Tun C, Quinones JN ,Kurt A Studied and showed that higher correlation of 12hr 
urine protein >165 correlated with a 24 hr urine protein >300 mg with the 
benefit of a shorter evaluation time for Proteinuria. 
Adelberg AM, Miller J, Doezbacher M Studied 65 hypertensive women and 
showed that total protein values of 8 & 12 HRS correlate positively with values 
of 24 hrs sample for patients with Proteinuria. The results of  12 and 24 hrs 
coincides in cases even without Proteinuria. 
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III. AIM OF THE STUDY 
 
The objective of the study was to know if 12h hrs urine protein would 
provide an accurate quantification of proteinuria and whether it can replace the 
use of 24 hrs urine protein in hypertensive disorders  of pregnancy 
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IV. MATERIALS AND METHODS 
This study was conducted at the department of obstetrics and  
gynaecology, Govt R.S.R.M Lying in hospital attached to Stanley Medical 
college, Royapuram ,Chennai. 
STUDY PERIOD: 
The study period was from August 2012 –July 2013. 
STUDY DESIGN: 
A total of 100 pregnant women > 20 Weeks gestation with   
preeclampsia and gestational hypertension attending Government RSRM Lying 
in Hospital attached to STANLEY MEDICAL COLLEGE Chennai will be 
selected consequently as and when they are presented with following inclusion 
and exclusion criteria. 
INCLUSION CRITERIA:           
 Pregnant women with preeclampsia or gestational hypertension with 
blood pressure140/90mm Hg or more,  recorded on two occasions 6 hrs 
apart.  
 Single diastolic blood pressure recording   of 110mm Hg.  
 Presence of proteinuria of trace or more detected by a test done on a 
random urine sample. 
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EXCLUSION CRITERIA: 
 Chronic hypertension 
  Preexisting renal disease 
 Gestational Diabetes Mellitus. 
METHODOLOGY:  
Those patients  who satisfy the above criteria are to  be  selected  for the  
study.  
The test has to be carried out in hospitalized patients. 
 A detailed history has to be taken.  
 General physical examination.  
 Systemic examination.  
 Obstetric examination.  
 
A qualitative urine test for urine protein has to be done on a  
random urine sample using dipstick method and graduated as follows   
 
 
 TRACE      15mg/dl 
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             1+             30mg/dl<0.5 gm/ day 
             2+            1oomg/dl                 0.5 -1 gm/ day 
             3+             3oomg/dl                 1 -2 gm/ day 
             4+             2gm/dl> 2 gm / day 
The test has to be repeated and if the repeat  test  shows trace or  
above quantitative estimation  for proteinuria has to be carried out as follows 
The patient should be instructed to collect the 24 hr urine specimen  
from the second urine sample  as two consecutive 12 hr collections in separate 
containers.The containers should be labeled with the patients name, age, IP NO. 
For emergency purposes sample can be  collected at any time of day. At the 
hour selected to start the patient have to urinate and discard the sample and start 
collecting from the next sample. Collect all the urine passed in a clean container 
and immediately transfer to the collection bottle .Have the patient pass the last 
urine at the end of 24 hr period and add into the bottle .The container must b 
kept in the refrigerator at all times  during the 24 hrs collection. 
The following factors affect the test sample 
 Lack of fluid ( Dehydration ) 
 Vaginal secretion 
 Severe emotional stress. 
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 Strenuous exercise. 
 Urinary tract infection. 
The best way to avoid retention error is to have the patient well hydrated  and 
positioned in lateral recumbency position  before starting and finishing the 
collection which minimizes the dead space errors and ensure that any urine in 
the urinary tract or bladder is of recent origin. 
The total urine volume  collected is measured by graduated cylinders and send 
to the laboratory as early as possible and total protein were measured  by 
pyrogallol Red Molybdate method.6ml of 12 hrs sample was taken as the first 
sample, the remaining first 12 hr sample is mixed with the second 12 hour 
sample and 6ml of the result solution was considered as second sample. 
Proteinuria is defined as >150mg in 12hours and >300mg in 24 hours.  
NORMAL VALUES OF PROTEIN EXCRETION (93): 
           In the 24 hrs urine protein estimation upto 300mg is assigned as no 
proteinuria, mild proteinuria is 300 -3000 mg and severe  proteinuria is > 
3000mg.in the 12 hrs urine protein estimation < 165mg is assigned as no 
proteinuria ,165 -1650 mg is considered as mild proteinuria and >1650 mg is 
considered as severe proteinuria.( 9)  
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 12 hrs urine protein 
(mg/dl) 
24 hrs urine protein 
(mg/dl) 
NO PROTEINURIA <165 <300 
MILD PROTEINURIA 165-1650 300 -3000 
SEVERE 
PROTEINURIA 
>1650 >3000 
 
Semi Auto Analyser With Microproteinuria Kit Used For The Study: 
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METHODS: 
The urine protein concentration is measured in the laboratory by   
pyrogallol red molybdate method. 

 Measure the 24 hrs urine volume in ml.  

 Divide the volume by 100 to determine the volume expressed in decilitre.  

 Multiply the 24 hrs urine volume in dl by the protein concentration in 
mg/dl as determined by Pyrogallol Red Method,(96) 

 The resulting number is the amount of protein expressed as mg/dl. 
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V. STATISTICAL ANALYSIS 
The data thus collected were analyzed using appropriate statistical methods. The 
mean and standard deviations were computed. The statistical tests used for 
analyses were the 
 Pearson correlation coefficient which is expressed as r.  
 Student Chi square test expressed as p value of p < 0.05 has been 
considered to be statistically significant. 
Table 1: Demography: 
 N 
Minimu
m 
Maximu
m Mean 
Std. 
Deviation 
Age in years 
100 17 40 23.87 4.228 
Gestational Age 
100 24 38 35.16 3.719 
SBP 
100 130 180 149.10 9.650 
DBP 
100 90 110 94.10 5.877 
12Hrs Urine 
Protein 100 40 2280 543.52 656.107 
24Hrs Urine 
Protein 100 88 4450 1044.61 1262.626 
Valid N (list wise) 
100     
 
This tabulation demonstrates the various variables dealt in the study their 
distribution, mean, standard deviation. In the present study it is observedthat the 
mean SD of age of the subject studied was 23.87 4.22, gestational age was 
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35.16 3.719, SBP was 149.1 9.65, DBP was 94.1 5.877, 12 hrs urine 
protein was 543.5 656.1, 24 hrs urine protein was 1044.6 1262.6. 
Table 2: Age wise distribution of cases: 
Age No.of pts Percentage % 
<21 45 45% 
21-28 43 43% 
>28 12 12% 
Total 100 
                                                
100% 
 
MacGillivary (1958) showed a J shaped curve between the relationship of 
maternal age and incidence of preeclampsia with high incidence among young 
and elderly age groups. In our study also there is a higher incidence among age 
groups 17-21 (45%) and >28 yrs(12%) together they make up 57%.   In our 
study the minimum age of the patient is 17 yrs and maximum age is 40 yrs. 
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Chart 1: Age wise distribution of cases: 
 
 
 
Table 3: Age wise distribution of cases according to the degree of Proteinuria: 
12Hrs Urine protein 24Hrs Urine Protein 
No 
Proteinur
ia 
Mild 
proteinur
ia 
Severe 
Proteinur
ia 
No 
Proteinur
ia 
Mild 
proteinur
ia 
Severe 
Proteinur
ia 
Age 
in 
year
s 
17-
21 21 18 6 20 19 6 
22-
78 8 28 7 7 28 8 
>2
8 5 5 2 5 5 2 
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In our study there is an excellent correlation between 12 hrs urine protein and 
24 hrs urine protein among various age groups and various degrees of 
proteinuria. This table shows that among the 34 cases who had no proteinuria in 
the 12hrs group 32 cases had no proteinuria 2 cases had mild proteinuria. 
Among the 51 cases who had mild proteinuria in the 12 hrs group all had mild 
proteinuria even in the 24 hrs group. Among the 15 cases who had severe 
proteinuria in the 12 hr group all had severe preeclampsia and one patient who 
had mild proteinuria in the 12 hr group . 
Chart 2:Age wise distribution of cases according to the proteinuria:
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Table: 4: Parity wise distribution of Cases: 
 
Parity No.of pts 
Primi 66 
Multi 34 
 
           The above table and chart shows the distribution of cases with 
preeclampsia according to parity. According to various theories preeclampsia is 
more common in nulliparous women. In our study among the 100 cases 66 are 
nulliparous and 34 are multiparous with a P value < 0.001 which is    
statistically highly significant.   
Chart 3: Parity wise distribution of Cases: 
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Table 5: Parity wise distribution of cases according to the degree of Proteinuria: 
Primi Multi 
12Hrs Urine protein No priteinuria 22 11 
Mild proteinuria 35 17 
Severe proteinuria 7 6 
24Hrs Urine protein No priteinuria 22 10 
Mild proteinuria 34 18 
Severe proteinuria 10 6 
 
           This table demonstrates the distribution of various degrees of proteinuria 
among primigravida and multigravida. There is no difference in the distribution 
of various degrees of proteinuria and gravida in both 12/24 hrs urine protein 
sample.   Hypertensive disorders of pregnancy were common in primi. Sibai& 
colleagues (1993) confirmed the higher risk of developing hypertension in the 
first pregnancy. According to a study conducted in cape peninsula (1979-81) 
there was double the incidence of hypertension & proteinuria in primi. 
 In our study primi constitutes 66% with a p value of <0.001which is 
statistically significant, it correlates with the studies. 
 
 
 
 
 
61 
 
Chart 4: Parity wise distribution of cases according to the degree of 
Proteinuria: 
 
 
 
Table6: Distribution of cases according to urine Dipstick Analysis: 
 
Urine Dipstick No. of Patients 
No Proteinuria 34 
Mild proteinuria 61 
Severe Proteinuria 5 
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According to urine dipstick trace is graded as no proteinuria, 1+, 2+, 3+ are 
graded as mild proteinuria, and 4+ is graded as severe proteinuria. In our study 
34% of cases had no proteinuria, 61% had mild proteinuria and 5% had severe 
proteinuria. 
Chart 5: Distribution of cases according to urine Dipstick Analysis: 
 
Table7: Correlation between Urine Dipstick with 12 and 24hrs Urine Protein: 
12Hrs Urine protein 24Hrs Urine Protein 
No 
Proteinuria 
Mild 
proteinuria 
Severe 
Proteinuria 
No 
Proteinuria 
Mild 
proteinuria 
No 
Proteinuria 32 2 0 32 2 
Mild 
Proteinuria 2 48 11 0 50 
Severe 
Proteinuria 0 1 4 0 0 
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In our study among the 34 patients who were diagnosed to have no proteinuria 
by dipstick had mild proteinuria in 2cases and no proteinuria in 32 cases in both 
12 and 24hrs urine protein. Among 61 cases who were diagnosed to have mild 
proteinuria by dipstick 2 had no proteinuria, 48 had mild and 11 had severe 
proteinuria, whereas in 24hrs group 50 had mild and 11 had severe proteinuria.  
Out of 5 cases who were diagnosed to have severe proteinuria by dipstick 1 had 
mild and 4 had severe proteinuria by 12hrs, whereas in 24hrs group all 5 had 
severe proteinuria. There is a statistically significant (p= 0.001) difference 
between urine dipstick and 12/24hrs urine protein. 
Chart 6: Correlation between Urine Dipstick with 12 and 24hrs Urine Protein: 
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Table8: Distribution of cases according to the Gestational Age: 
 
Gestational Age No. Of Patients 
<28 weeks 12 
29-34 weeks 20 
>34 weeks 68 
 
Among the 100 cases studied 68 cases were > 34 weeks, 12 cases were <28 
weeks and 20 cases were between gestational age 29 to 34 weeks. According to 
various studies hypertensive disorders of pregnancy are common during later 
periods of gestation which correlates with our study. 
Chart 7: Distribution of cases according to the Gestational Age: 
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Table9: Distribution of proteinuria according to the Gestational Age: 
There is a good correlation between 12 and 24 hours urine protein in all degrees 
of proteinuria among various gestational age groups. Among the 24 cases in the 
> 34 weeks gestational age who had no proteinuria in 12 hrs sample 23 cases 
had no proteinuria even in the 24 hrs sample. Likewise mild and severe 
proteinuria also correlates in this gestational age. 
Chart 8: Distribution of proteinuria according to the Gestational Age: 
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Table10: Distribution of cases according to the type of Hypertension: 
 
Type of HT No. of patients 
GHT 34 
PE 44 
SPE 18 
RPE 4 
 
Among the 100 cases studied 34 had gestational hypertension, 44 had 
preeclampsia, 18 had severe preeclampsia and 4 had recurrent preeclampsia. 
The blood pressure among the cases ranges between 140/90 to 180/110 mmHg 
with mean systolic blood pressure of 149.10 mmHg and diastolic blood pressure 
of 94.10 mmHg.  
Chart 9: Distribution of cases according to the type of Hypertension 
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Table 11: Correlation between 12 and 24 hrs urine Protein and types of HT 
 
Out of the 34 patients who were diagnosed as gestational hypertension 32 had 
no proteinuria, 2 had mild proteinuria. Likewise 48 patients who were 
diagnosed as preeclampsia (PE&RPE) 2 had no proteinuria, 46 had mild 
proteinuria. Likewise 18 patients who were diagnosed as severe preeclampsia 3 
had mild proteinuria, 15 had severe proteinuria. p value for both 12 and 24 hrs 
urine protein was 0.001, so there is statistically significant correlation between 
types of hypertension and 12/24 hrs urine protein. 
 
Typ
e Of 
HT 12 hrs Urine Protein 24 hrs Urine Protein 
No 
Proteinuri
a 
Mild 
proteinuri
a 
Severe 
Proteinuri
a 
No 
Proteinuri
a 
Mild 
proteinuri
a 
Severe 
Proteinuri
a 
GH
T 32 2 0 32 2 0 
PE 2 42 0 0 44 0 
SPE 0 3 15 0 2 16 
RPE 0 4 0 0 4 0 
0.001 0.001 
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Chart 10: Correlation between 12 and 24 hrs urine Protein and types of HT 
 
Table 12: Maternal Outcome among the cases: 
Maternal Outcome No.Of Patients 
Good 84 
Adverse 16 
 
The overall maternal outcome was good in no proteinuria group in both 12 and 
24 hrs urine protein study.The percentage of adverse maternal outcome was less 
in mild preeclampsia group when compared to severe preeclampsia in both 12 
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and 24 hrs  steudy. The adverse maternal outcomes like terminatination of 
pregnancy on maternal or fetal grounds leading to increaser rate of caesarean 
section, starting Mgso4 regimen, antepartum eclampsia, abruption, HELLP 
syndrome. 
Chart:  11: Maternal Outcome among the cases: 
 
 
Table: 13: Correlation between Maternal outcome and severity of Proteinuria: 
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          In the 12 hrs urine protein, out of the 34 patients with no proteinuria all 
the patients (100%) had good maternal outcome. Among the 51 patients with 
mild proteinuria only 6(11.7%) patients had adverse outcome. Whereas among 
16 patients among severe proteinuria group 10 (66.7%) had adverse outcome. 
This is similar to the 24 hrs urine protein where among the 52 patients who had 
mild proteinuria 5( 9 .6 %) had adverse outcome and among the 16 patients in 
severe preeclampsia group 11(68.7%) had adverse outcome. 
Chart 12: Correlation between Maternal outcome and severity of Proteinuria 
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Table 14: Fetal outcome among Cases 
Fetal outcome No.Of Patients 
Good 74 
Adverse 26 
 
The fetal outcome was good when there is no proteinuria, and fetal 
complications occur when there is mild or severe proteinuria.The adverse 
neonatal outcomes includes preterm delivery, low birth weight, IUGR , low  
APGAR score,NICU admission. Among the 100 patients neonatal outcome was 
affected in 26 cases. 
Chart: 13: Fetal outcome among Cases: 
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Table 15: Correlation between Fetal outcome and severity of Proteinuria 
 
The above table shows that fetal outcome worsens with the degree of 
proteinuria the outcome is good when there is no proteinuria and most of the 
babies had an adverse outcome when there is severe proteinuria .In the 12 hrs 
sample in the severe proteinuria group 93.2% had adverse outcome which is 
very similar to to the 24 hrs urine sample which shows 93.7% adverse outcome 
in the severe preeclampsia group. In the mild proteinuria group adverse 
outcome occurs in 23.5% in the 12hrs study and 21.1% in the 24hrs study which 
is statistically significant with a P value of 0.001. 
 
 
 
 
 
12Hrs Urine protein 24Hrs Urine Protein 
No 
Proteinuria 
Mild 
proteinuria 
No 
Proteinuria 
Mild 
proteinuria 
Severe 
Proteinuria 
Good 34 39 32 41 1 
Adverse 0 12 0 11 15 
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Chart 14: Correlation between Fetal outcome and severity of Proteinuria: 
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Table 16: Correlation between 12Hrs and 24Hrs urine Protein: 
  24Hrs Urine Protein Total 
  No Mild Severe  
12Hrs 
Urine 
Protein 
No Count 
32 2 0 34 
  % within 12Hrs 
Urine Protein 94.1% 5.9% .0% 100.0% 
  % within 24Hrs 
Urine Protein 100.0% 3.8% .0% 34.0% 
 Mild Count 0 49 2 51 
  % within 12Hrs 
Urine Protein .0% 96.1% 3.9% 100.0% 
  % within 24Hrs 
Urine Protein .0% 94.2% 12.5% 51.0% 
 Severe Count 0 1 14 15 
  % within 12Hrs 
Urine Protein .0% 6.7% 93.3% 100.0% 
  % within 24Hrs 
Urine Protein .0% 1.9% 87.5% 15.0% 
Total Count 32 52 16 100 
 % within 12Hrs 
Urine Protein 32.0% 52.0% 16.0% 100.0% 
 % within 24Hrs 
Urine Protein 100.0% 
100.0
% 100.0% 100.0% 
 
Table:17: Chi-Square Test for Comparing 12 and 24hours Urine Protein: 
 Value df 
Asymp. Sig. (2-
sided) 
Pearson Chi-Square 167.164(a) 4 .000 
Likelihood Ratio 160.139 4 .000 
Linear-by-Linear 
Association 88.586 1 .000 
Among the patients who had no proteinuria in the 12 hrs study 94.1% had no 
proteinuria and 5.9% had mild proteinuria in the 24 hrs study.Among the 
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patients who had mild proteinuria in the 12 hrs study 96.1% had mildproteinuria 
and 3.9% had severe proteinuria in the 24 hrs study.Among the patients who 
had severe  proteinuria in the 12 hrs study 6.7% had mildproteinuria and 93.3% 
had severe proteinuria in the 24 hrs study.The  study shows a pearson chi-square 
value of 0.001 which is statistically significant.Thus 12 and 24 hrs sample 
coincides in all degrees of proteinuria in all ages at all gestational ages and 
various degrees of hypertension. 
Table:18: PEARSONS Correlation coefficient for Comparing 12 and 
24hours Urine : 
The pearson’s correlation coefficient (r) value comparing 12 and 24 hrs urine 
protein was 0.946 which correlates with other studies. 
STUDIES CORRELATION COEFFICIENT 
(r) 
SOGRE RABIE 0.86 
CHRISTINA TUN 0.99 
RANGASAMY SAVITHA O.96 
OUR STUDY 0.94 
 
 Value 
Asymp. 
Std. 
Error(a) 
Approx. 
T(b) 
Approx. 
Sig. 
Interval by 
Interval 
Pearson's R 
.946 .024 28.873 .000(c) 
Ordinal by 
Ordinal 
Spearman 
Correlation .950 .022 30.245 .000(c) 
N of Valid Cases 100    
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Chart 15: Correlation between 12Hrs and 24Hrs urine Protein: 
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Table 18: Statistical Significance  
 
  24Hrs Urine Protein Total 
  Normal 
Abnorma
l  
12Hrs Urine 
Protein 
Normal Count 32 2 34 
  % within 
12Hrs Urine 
Protein 
94.1% 5.9% 100.0% 
  % within 
24Hrs Urine 
Protein 
98.1% 2.9% 34.0% 
 Abnormal Count 0 66 66 
  % within 
12Hrs Urine 
Protein 
.0% 99.0% 100.0% 
  % within 
24Hrs Urine 
Protein 
.0% 97.1% 66.0% 
Total Count 32 68 100 
 % within 
12Hrs Urine 
Protein 
32.0% 68.0% 100.0% 
 % within 
24Hrs Urine 
Protein 
100.0% 100.0% 100.0% 
 
The above table explains the statistical significance of the study comparing the 
accuracy of 12 hrs urine protein with 24 hrs urine protein in predicting 
proteinuria with a Sensitivity of 98.1% , Specificity of 97.1%, Positive 
predictive value of 94.1%, Negative predictive value 99%.  
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VI. DISCUSSION 
In our study 100 patients with hypertensive disorders of pregnancy were 
enrolled after fulfilling the inclusion & exclusion criteria. 
INCIDENCE: 
Study Incidence of Preeclampsia 
Mudaliar & Menon       10% 
Sanchez Ramos 14% 
 
Ritu Kamare et al         13.6% 
 
Rodriguerz et al           10.6% 
 
Present Study              9.6% 
 
In our hospital the incidence of preeclampsia was 9.6%. 
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AGE INCIDENCE: 
Women of different age group were included in the study. Out of the 100 
patient 67% of them were in the age group between 17 to 21 &>28 years which 
is in accordance with the study of Mac Gillivary (1958) which showed a J 
shaped curve between the relationship of maternal age & incidence of 
hypertensive disorders of  pregnancy. 
Similarly a study by Remich (1989) in Virginia showed a significant 
relationship between maternal age & incidence of pre eclampsia. 
Hansen reported 2 to 3 – fold increase in preeclampsia over 30 years. 
PARITY: 
Hypertensive disorders of pregnancy were common in primi. Sibai& colleagues 
(1993) confirmed the higher risk of developing hypertension in the first 
pregnancy. According to a study conducted in cape peninsula (1979-81) there 
was double the incidence of hypertension & proteinuria in primi. 
In our study primi constitutes 66% with a p value of <0.001which is statistically 
significant, it correlates with the studies. 
SOCIO ECONOMIC STATUS:  
 Low socio economic status is reported to have high incidence of hypertensive 
disorders of pregnancy. This may be attributed to their poor nutrition. 
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In our study most of them belong to class IV & V socio economic 
atatus.Dr.Dawn (1964) & Dr.Richares nage (1981) showed that maternal 
nutririon exerts its regulating effect on the fetal growth through its effect on 
blood volume, blood pressure & utroplacental blood flow. This correlates with 
our study. 
GESTATIONAL AGE:  
The averagegestational age in our study is 35.1 weeks. About 68% cases 
develop HT >34 weeks, According to various studies hypertensive disorders are 
common during later periods of gestation. 
Correlation between dipstick analysis & 12/24 hours urine Protein: 
In our study there is poor correlation between urine dipstick & 12/24 hours 
urine protein with ap value of 0.001 which is statistically significant. 
Suden et al showed that the high number of false negatives with urine dipstick 
when compared to 24 hours urine measurement. 
Mayer et al found that dipstick is apoor predictor of absent or severe 
proteinuria. 
Jasone et al showed dipstick values of trace or 1+ correlates poorly whereas at 
higher degrees it correlates better. 
According to the type of hypertension: 
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Among the 100 patients in the study, 34 had gestational hypertension, 48 had 
preeclampsia of which 4 patients had recurrent preeclampsia & 18 had severe 
preeclampsia. In all types of hypertensive disorders of pregnancy there is a very 
good correlation between 12&24 hours urine protein with a p value of 0.001, 
which is statistically significant.  
Maternal Outcome:   
The maternal complications that are common in preeclampsia & proteinuria are 
eclampsia, abruption placenta mgso4 regimen, DIC, HELLP syndrome. There is 
increase in rate of termination of pregnancy for maternal interest by induction of 
labour which ends in increase in rate of caesarean section and preterm delivery. 
Eclampsia: 
Hibaral (1973) showed that about 20% of maternal death in preeclampsia is due 
to eclampsia. In a study conducted by Basker Rao in 1971 incidence of 
eclampsia in hospitalised patients was 3% & 6% on unbooked case. In our study 
eclampsia occurs in 4 cases i.e., 4% which correlates with the study. All these 
cases belong to severe proteinuria group. 
Abruptio Placenta: 
In 1997 a study conducted by Hollier and Cunningham showed that the risk of 
abruption was 2.1 to 4 %. In our study incidence of abruption was 2%    
Which correlates with that study.  
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Mgso4 Regimen: 
It is an anticonvulsant used in the treatment of severe preeclampsia out of the 
100 patients in our study mgso4 regimen was started in 8 cases. All of these 
belong to severe proteinuria group.  
Course of Labour: 
In 1966 shiring showed that preeclampsia is a  common cause of induction of 
labour. In our study, pregnancy was terminated for maternal and fetal intrest in 
17 cases which leads to increased rate of caesarean section and preterm birth 
Fetal Outcome: 
The common complications associated with severe proteinuria are low birth 
weight, IUGR, oligohydramnios, preterm birth, low APGAR scores. The 
incidence of IUGR in our study was 8% , 15%  preterm birth, 2% still born, 6% 
oligohydramnios. In a study conducted by Doss et al (1998) prematurity was 
17.6% which correlates with our study. According to mudaliar and menon the 
incidence was 22%. 
Indir (1984) showed that incidence of IUGR in severe proteinuria is 8% which 
correlates with our study.  
Correlation between 12 hrs and 24 hrs urine protein: 
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There is a significant correlation between 12 and 24 hrs urine protein in all 
types of hypertension ( GHT, PE, SPE ) and in all degrees of proteinuria ( No, 
mild , severe ). The study shows a Pearsons Chi square value of 0.001 which is 
statistically significant. 
Sogre Rabie P < 0.01 
Otero Pinto P<0.01 
Christina Tun P <0.001 
Rangasamy Savitha P <0.0001 
Irrvae P <0.02 
Our Study P <0.001 
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SENSITIVITY AND SPECIFICITY : 
The datas thus collected are analysed using appropriate statistical methods and 
sensitivity and specificity are tabulated. 
STUDY SENSITIVITY 
         % 
SPECIFICITY             
% 
POSITIVE 
PREDICTIVE 
VALUE % 
NEGATIVE 
PREDICTIV
E VALUE % 
Minoo 
Rajaei 
(n=63) 
83 91 80 82 
Sogre 
Rabiae ( 
n=57) 
94 99 98 99 
Christina 
Tun 
(n=102) 
96 100 100 98 
Sogre 
Fillahi (n= 
65) 
82 88 85 86 
Irruae 
(n=65) 
96 98 98 96 
Our Study 
(n=100) 
98 97 94 99 
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CORRELATION COEFFICIENT: 
                        The correlation coefficient r value comparing 12 and 24 hrs urine 
protein was 0.94  which is similar to other studies. 
 
STUDIES CORRELATION COEFFICIENT 
(r) 
SOGRE RABIE 0.86 
CHRISTINA TUN 0.99 
RANGASAMY SAVITHA 0.96 
OUR STUDY 0.94 
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                                          SUMMARY 
* The study is conducted in hospitalised patients above 20 weeks of gestation 
with hypertensive disorders of pregnancy. 
* Since the level of urinary protein excretion has considerable clinical 
implications in the course of pregnancy and on the perinatal and neonatal 
outcome the early detection of even minor degrees of proteinuria is important. 
* For years 24 hrs urine collection has been the gold standard for quantitation of 
proteinuria in the management of women with preeclampsia, however this 
method is cumbersome subjective to collection errors requires good patient 
compliance and results in the delay in the diagnosis > 24 hrs from the start of 
collection. 
* Proteinuria is proved to be an important predictor of maternal and fetal 
outcome. As the degree of proteinuria increases there is increase in neonatal and 
maternal morbidity and mortality. 
* This study shows that there is high degree of correlation between 12 and 24 
hrs urine protein in all types of hypertension and all degrees of proteinuria. 
* Our studyshowed that 12 hr sample correlated with 24 hrs sample for patients 
with no proteinuria (p < 0.001 ) mild proteinuria (p<0.001), severe proteinuria ( 
p < 0.001 ) which is statistically significant. 
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* The correlation coefficient (r) between 12 and 24 hrs urine protein is 0.94 
which is statistically significant. 
* The statistical significance of the study comparing the accuracy of 12 hrs 
urine protein with 24 hrs urine protein in predicting proteinuria with a 
Sensitivity of 98.1% , Specificity of 97.1%, Positive predictive value of 94.1%, 
Negative predictive value 99%. 
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VII. CONCLUSION 
Our study showed that `there is a high correlation of 12 hrs urine protein 
>165mg with a 24 hrs urine protein>300mg in all degrees of proteinuria and all 
types of hypertension.  
The present study indicates that this method of quantification of proteinuria 
when properly interpreted can provide valuable information that for clinical 
purposes is a satisfactory substitute for the determination of protein excretion in 
a 24 hr collection. 
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B.PROFORMA SHEET 
 
NAME:      
AGE:               IP NO:                  UNIT:                   S.NO: 
 
DATE OF ADMISSION: 
DATE OF DELIVERY: 
DATE OF DISCHARGE: 
SOCIOECONOMIC STATUS: 
LAST MENSTRUAL PERIOD: 
EXPECTED DATE OF DELIVERY: 
 
OBSTETRIC CODE: 
                                G       P     L     A 
ADMITTED FOR:    Safe Confinement 
                                 Labour pains/ draining/bleeding/pedal edema 
                                 Headache/blurring of vision/ oliguria 
                                 Convulsions 
MENSTRUAL HISTORY:     Regular/ Irregular 
                                              LMP: 
MARITAL HISTORY: Married since 
                                   Consanguinity- 
OBSTETRIC HISTORY: G    P    L    A 
Nature of previous deliveries: 
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 Labour natural/ caesarean section /Termination 
 
PRESENT PREGNANCY: 
I TRIMESTER: Fever, Drug intake, Radiation, Bleeding per vaginum. 
                                  II TRIMESTER: Bleeding, Pedal Edema, Vomiting, 
Headache, Visual Disturbances. 
                                  III TRIMESTER: Bleeding, Pedal Edema, Vomiting, 
Headache, Visual Disturbances. 
PAST HISTORY:  
                         Gestational Hypertension, Preeclampsia, Renal Disease 
FAMILY HISTORY: 
                         Hypertension, epilepsy, Diabetes 
MEDICAL HISTORY: 
                        Chronic Hypertension, Diabetes Mellitus, Renal Disease 
 
GENERAL EXAMINATION 
 
           Built:                      
           Pallor: 
           Jaundice: 
           Pedal Edema: 
VITALS: 
                     Pulse Rate: 
                   Blood Pressure: 
Ist Reading: 
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IInd Reading: 
CARDIOVASCULAR SYSTEM: 
RESPIRATORY SYSTEM: 
        PER ABDOMEN: 
                          Height of uterus: 
                          Acting/ not acting: 
                       Tense /Tender: 
                       Liquor: 
 
 
INVESTIGATIONS:  
Urine:     Alb: 
                                              Sugar and deposits: 
Blood:   Hb %:  
                                              Total count: 
                                              Platelets: 
                                              Gr/ Typing:  
                                             Blood Urea:  
                                              Blood Sugar:  
                                              Serum Creatinine:  
 Liver function Tests: 
                  Serum Bilirubin: 
                  Serum Proteins: 
                  SGOT:  
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                  SGPT: 
                  SAP: 
Serum uric acid : 
Serum fibrinogen: 
12hrs urine protein: 
24hrs urine protein: 
Fundus  
 
 TREATMENT: 
Antihypertensive: 
                  Magnesium sulphate Regimen: 
LABOUR: 
                  Mode of Delivery: 
                                 Labour Natural/ Caesarean Section/ Termination 
 
COMPLICATIONS: 
             MATERNAL: 
                        Eclampsia 
                        Abruption 
                        HELLP 
                       Pulmonary Edema 
            BABY: 
                       Alive/ Stillborn/ intra uterine Death 
C.ABBREVATIONS 
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SBP –Systolic Blood Pressure 
DBP –Diastolic Blood Pressure 
GHT – Gestational Hypertension 
PE –Preeclampsia 
PCR – Protein Creatinine Ratio 
IUGR –Intra Uterine Growth Restriction 
TXA2 – Thromboxane A2 
PGI2 –Prostaglandin I2 
Sflt –Soluble fms like Tyrosine Kinase 1 
S(Eng)- Soluble Endoglin 
AST –Aspartate transaminase 
ALT –Alanine Transaminase 
LBW – Low Birth Weight 
 
 
 
 
MASTER CHART FOR 100 CASES OF HYPERTENSIVE DISSORDERS OF PREGNANCY 
Sl.No Name Age IP No 
Obstetric 
Code 
Gestational 
Age 
Urine 
Albumin SBP DBP 
Type 
of HT 
Platelet 
Count 
Uric 
Acid 
12Hrs 
Urine 
Protein 
24Hrs 
Urine 
Protein 
Mode of 
delivery Maternal outcome 
Fetal 
outcome 
1 Vasanthi 28 4708 Primi 36 1+ 140 100 PE 2.5 5.2 232 450 LN Good Good 
2 Jayashree 25 4846 Primi 26 4+ 160 100 SPE 1.7 7.2 1600 3500 LSCS Abruption Preterm 
3 Allice Mary 30 4088 G2P1L1 Term 1+ 150 90 RPE 2 5.3 260 525 LSCS Good Good 
4 Karuna 28 4833 Primi 32 3+ 160 90 SPE 2.3 7 1700 3200 LN Good Preterm 
5 Jothi 26 4922 G2P1L1 Term 1+ 150 90 RPE 2.1 6.5 378 785 LN Good Good 
6 Helen 30 4955 G2P1L1 36 Trace 140 90 GHT 2.8 4 78 165 LN  Good Good 
7 Kushboo 19 4558 Primi Term 1+ 160 100 PE 3 4.5 190 364 LN Good Good 
8 Nathiya 24 4584 G2P1L1 36 2+ 160 100 PE 2.9 4.8 218 420 LSCS Good LBW 
9 Murugavalli 21 4828 Primi Term 2+ 160 100 PE 2.4 7.2 300 608 LSCS MGSO4 regimen IUGR 
10 Vijayamma 20 4969 Primi Term 1+ 140 90 PE 2.5 4.5 770 1500 LN Good Good 
11 Indumathy 27 5027 G2P1L1 Term Trace 140 90 GHT 2.8 3.8 40 88 LN Good Good 
12 Ramalakshmi 25 5164 G2P1L1 34 1+ 140 90 PE 2.4 5.6 204 410 Conservative management 
13 Jagadeshwari 20 5004 Primi 24 3+ 180 110 SPE 2 8.2 1948 3950 Termination Stillborn 
14 Bavani 19 5009 Primi 36 1+ 150 100 PE 3 4.5 250 508 LN Good Good 
15 Shobana 26 5669 Primi 32 3+ 180 100 SPE 2.3 7.8 1850 3800 Termination MGSO4 regimen Preterm 
16 Shanavas 28 5736 Primi 34 1+ 150 100 PE 2.1 6.8 296 606 LSCS Good Preterm 
17 Gowri 21 5743 Primi 34 1+ 150 90 PE 2.5 4.2 185 350 Conservative management 
18 Revathy 19 5755 Primi 36 1+ 150 90 PE 1.8 5 208 420 LN Good Good 
19 Sumathy 27 6079 G2P2L2 Term Trace 140 90 GHT 2.8 3.6 142 175 LN Good Good 
20 Fathima 28 6218 Primi 36 1+ 140 90 PE 2.3 4.1 255 520 LN Good Good 
21 Lakshmi 30 6416 G2P1L1 34 Trace 130 90 GHT 3 5.1 45 92 EM 
  22 Amutha 25 6287 Primi Term 2+ 150 90 PE 2 4 275 575 LN Good Good 
23 Gurupriya 21 6485 Primi Term 1+ 160 90 PE 2.5 4.2 416 848 LN Good Good 
24 Badurunisha 21 6715 Primi 36 Trace 140 90 GHT 3.2 4.8 105 220 LN Good Good 
25 Menaka 32 7224 Primi 32 Trace 130 90 GHT 1.9 4.5 42 90 EM 
  26 Girija 26 7392 G2P1L1 28 3+ 160 100 SPE 2.1 7.2 1705 3450 LSCS IE Preterm 
27 Amulu 29 7758 G2P1L1 32 Trace 140 90 GHT 2.5 3.8 74 156 EM 
  28 Karpagam 24 7985 Primi 36 Trace 140 90 GHT 3 5 110 225 LN Good Good 
29 Kasthuri 40 7325 G2P1L1 32 Trace 140 90 GHT 2.8 4.2 110 230 EM Good 
 30 Yasmine Banu 22 8044 Primi 32 Trace 140 90 GHT 3.2 4.8 168 320 EM 
  31 vimala 19 8286 Primi Term Trace 140 90 GHT 3 3.6 180 338 LN Good Good 
32 Bavani 20 8266 Primi 28 Trace 150 90 GHT 2.6 5.2 135 254 EM 
  33 Syed sulthana 20 8358 Primi 32 Trace 140 90 GHT 2.8 5.2 115 206 EM 
  34 Meena 20 9050 Primi 36 1+ 150 90 PE 2.4 6 225 442 LSCS Good Preterm 
35 
Shamim 
fathima 27 9091 G2P1L1 34 2+ 160 100 PE 2 7.9 456 940 LSCS Good LBW 
36 Lakshmi Devi 24 9048 G2P1L1 36 1+ 140 100 PE 2.2 6.5 610 1200 LN Good Preterm 
37 Chinthamani 21 9142 Primi Term Trace 140 90 GHT 2.9 5.2 116 240 LN Good Good 
38 Saritha 24 9512 G2P1L1 Term 2+ 140 90 PE 3 6 418 848 LN MGSO4 regimen Good 
39 Jayachithra 21 9644 Primi Term Trace 150 90 GHT 2.9 5.6 104 206 LN Good Good 
40 Abhitha 27 9649 G3P1L1A1 36 1+ 150 90 PE 3.1 6.1 198 390 LSCS Good Good 
41 Rajeswari 33 9648 G3P2L2 28 3+ 160 100 SPE 2 8 1900 3600 Termination MGSO4 regimen IUGR 
42 Valli 20 9878 Primi 28 Trace 140 90 GHT 1.7 4 76 146 EM 
  43 Malathi 25 9906 Primi Term 3+ 160 110 SPE 1.9 7.5 2198 4250 Termination MGSO4 regimen IUGR 
44 Saritha 19 9940 Primi 32 Trace 140 90 GHT 2 5.2 110 208 EM 
  45 Priya 21 9942 Primi Term 4+ 160 100 SPE 2.9 7.2 2236 4450 Termination Good IUGR 
46 Rekha 27 9988 Primi 36 Trace 140 90 GHT 3.4 5 110 206 LN Good Good 
47 Lakshmi devi 24 10128 G2P1L1 34 1+ 160 100 RPE 3 6.1 230 444 Termination Good Preterm 
48 Hemavathi 30 10204 Primi 28 4+ 150 100 SPE 2 7.6 1990 4010 Termination IE Stillborn 
49 Jaylakshmi 21 10215 Primi Term 1+ 140 100 PE 2.7 5.2 266 546 LN Good Good 
50 Suriya banu 25 10836 G3P1L1A1 Term 2+ 160 100 SPE 1.9 6.8 1582 3146 LSCS Abruption IUGR 
51 MUthammal 26 10878 G2P1L0 36 2+ 160 100 SPE 3 7.2 1730 2400 Termination IE Preterm 
52 Dhanalakshmi 28 10914 Primi Term 2+ 160 100 PE 2.5 7.6 462 880 LN Good Good 
53 Aarthi priya 25 10940 Primi Term 1+ 160 110 SPE 2.7 6.9 1380 2600 LN MGSO4 regimen Good 
54 Mehaboo bee 20 11014 G2P1L1 Term 1+ 160 100 RPE 3 6 930 1755 LSCS Good Good 
55 Vijayalakshmi 19 11213 G2P1L1 Term Trace 140 90 GHT 2.6 5 122 226 LN Good Good 
56 Ilavarasi 27 12746 G2P1L1 Term 1+ 160 90 PE 1.8 4.8 238 456 LN Good Good 
57 Kudiya devi 20 12830 G2A1 36 3+ 160 110 SPE 2 6.1 1700 3360 Termination Oligohydramnios Preterm 
58 Mathubala 19 13010 Primi 36 4+ 160 100 SPE 2.3 6.5 2246 4200 Termination MGSO4 regimen IUGR 
59 Rajeswari 21 13022 G2P1L1 Term Trace 140 90 GHT 3 4.8 122 228 LN Good Good 
60 Devi 26 13077 G2P1L1 Term Trace 140 90 GHT 3.2 4.8 130 244 LN Good Good 
61 Devika 25 13098 G2P1L1 32 2+ 150 100 PE 2 5.2 260 505 Termination IE Preterm 
62 Devi 31 13167 Primi 36 1+ 150 90 PE 2.9 5 400 744 LN Good Good 
63 
Shahana 
Begam 20 13189 Primi 36 3+ 160 100 SPE 2.6 7 1730 3200 Termination MGSO4 regimen Preterm 
64 Devi 26 13210 G2P1L1 28 4+ 160 100 SPE 2.5 7.1 1980 3740 Termination Good IUGR 
65 Usha 20 13244 Primi Term Trace 150 100 GHT 1.95 5 114 220 LN Good Good 
66 Nithya 19 13258 Primi Term Trace 140 90 GHT 2 4.5 150 280 LN Good Good 
67 Yasmin Begum 21 13185 G2P1L1 Term 1+ 150 90 PE 2.6 6 265 508 LSCS Good Good 
68 Kanchana 26 13385 Primi Term Trace 140 90 GHT 3.4 4.8 92 176 LN Good Good 
69 Vijayakumari 28 13447 Primi 36 1+ 140 90 PE 2.5 4 350 668 Termination Good Good 
70 Sathya 20 13448 Primi Term 2+ 150 100 SPE 2 6.1 1850 3400 LSCS Oligohydramnios Good 
71 Latha 33 13559 Primi 36 1+ 160 100 PE 2.1 5.6 920 1746 Termination Good Preterm 
72 Seetha 21 13578 Primi Term 1+ 150 90 PE 2.5 5 675 1256 LN Good Good 
73 Ramya 19 13638 Primi Term Trace 140 90 GHT 2.3 4.8 52 102 LN Good Good 
74 Vennila 24 13756 G4P2L1A1 Term 1+ 150 90 PE 1.9 4 400 778 LN Good Good 
75 Sudha 27 13757 G3P2L2 34 3+ 150 110 SPE 1.8 6 2280 4200 Termination Good Preterm 
76 Pallavi 20 13714 Primi Term Trace 140 90 GHT 2.2 4.6 135 256 LN Good Good 
77 Gajalakshmi 30 13767 G2P1L1 36 1+ 160 100 PE 2.6 5.2 345 660 Termination Good Preterm 
78 Kavitha 20 13786 Primi Term Trace 140 90 GHT 2.9 4 150 286 LN Good Good 
79 Meenakshi 28 13941 Primi Term 1+ 160 100 PE 2 5 698 1300 LN Good Good 
80 Vasanthi 20 14337 Primi Term Trace 140 90 GHT 2.6 4.4 100 185 LN Good Good 
 GHT - Gestational Hypertension, PE – Preeclampsia, SPE – Severe Preeclampsia, RPE – Recurrent Preeclampsia, SBP – 
Systolic Blood Pressure, DBP – Diastolic Blood Pressure, IUGR – Intra Uterine Growth Restriction , EM – Expectant 
Management , MgSo4 – Magnesium sulphate. 
81 Thamena 21 14351 Primi Term Trace 150 90 GHT 2.3 4.8 80 150 LN Good Good 
82 Karthika 20 14364 G2P1L1 Term Trace 150 90 GHT 2.1 4.2 120 225 LN Good Good 
83 Vijayalakshmi 20 14366 Primi Term 1+ 140 90 PE 2 5.2 200 380 LN Good Good 
84 Jayalakshmi 21 14368 Primi 32 Trace 140 90 GHT 3.1 4 110 200 EM 
  85 Priyanka 20 14367 Primi Term Trace 140 90 GHT 3.4 4.6 146 280 LN Good Good 
86 Nandhini 17 14383 Primi Term Trace 140 90 GHT 2.4 5 150 186 LN Good Good 
87 Revathy 25 14423 Primi 36 Trace 140 90 GHT 2.8 4.3 104 198 LN Good Good 
88 Nalini 20 14465 Primi 26 1+ 150 90 PE 2.6 4.2 210 408 EM 
  89 Vidhya 21 14482 Primi 32 1+ 150 90 PE 3 4.8 294 560 EM 
  90 Rani 26 14498 G2P1L1 34 1+ 150 100 PE 2.7 4.5 156 308 EM 
  91 Bavani 30 14513 Primi 26 1+ 150 90 PE 3.2 3.8 166 326 EM 
  92 Prema 20 14525 Primi Term 1+ 160 90 PE 3.7 5.2 428 790 LN Good Good 
93 Anu 24 14587 Primi 32 1+ 150 90 PE 2 5.6 200 380 EM 
  94 Barathi 25 14599 Primi 36 2+ 160 90 PE 3.1 5.3 412 805 LN Good Good 
95 Ramya 19 14619 Primi Term 2+ 160 90 PE 2.9 4.8 780 1500 LN Good Good 
96 Vinodini 18 14676 Primi 24 1+ 140 90 PE 2.8 3.9 160 310 EM 
  97 Anjali 26 14688 Primi 36 1+ 140 90 PE 2.6 4.1 256 480 LN Good Good 
98 Angammal 27 14690 Primi Term 2+ 150 90 PE 2.8 4.6 370 690 LN Good Good 
99 Uma 24 14709 G2P1L1 Term 2+ 150 100 PE 3.2 5.2 420 786 LN Good Good 
100 Vanitha 25 14756 Primi 28 1+ 140 90 PE 3.4 5.1 175 320 EM 
  
